gdc
Colorectal CancerSlideshows

Colorectal Cancer Awareness Month

March is Colorectal Cancer Awareness Month! Flip through this slideshow featuring the top risk factors for colorectal cancer, symptoms to look out for, and more. Conquer cancer with knowledge.
Web Exclusives – March 1, 2018
  • Colorectal Infographic1
  • Colorectal Infographic2
  • Colorectal Infographic3
  • Colorectal Infographic4
  • CQ Generic SlideshowEnder 800

Share this:

Recommended For You
Colorectal Cancer
Drugs for Colorectal Cancer
Find financial assistance programs available for colorectal cancer drugs.
Colorectal CancerMen's HealthSurvivorship
What It Really Means to “Man Up”
By Joe Bullock
Six months before he was diagnosed with stage IIIB colorectal cancer, both of Joe Bullock’s parents passed away. Chemotherapy hit him hard and stirred a mixture of depression and feelings of inadequacy as a husband and father. Then he discovered the power of opening up.
Colorectal Cancer
First-Line Treatment with Keytruda Doubles the Time without Disease Progression in Patients with MSI-H or dMMR Metastatic Colorectal Cancer
By Chase Doyle
New study results presented at the 2020 ASCO annual meeting suggest that there is a new standard of care for the first-line treatment of some patients with advanced colorectal cancer. This was the first study to compare the use of Keytruda (pembrolizumab), a PD-1 inhibitor, versus chemotherapy to see which is the best first treatment for patients with metastatic (spreading) colorectal cancer and microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) abnormalities.
Colorectal Cancer
Opdivo plus Yervoy May Be New First-Line Option for Patients with MSI-H or dMMR Colorectal Cancer
By Wayne Kuznar
The use of first-line immunotherapy combination with Opdivo (nivolumab) and low-dose Yervoy (ipilimumab) continues to show robust, long-term benefit in patients with microsatellite instability high (MSI-H) or with mismatch repair-deficient (dMMR) metastatic (spreading) colorectal cancer, according to new study results presented at the 2020 ASCO annual meeting.
Last modified: March 10, 2022

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country
Gender
Race or Ethnicity
Profession or Role
Primary Interest